Fingerprint
Dive into the research topics of 'Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
Suah Yang, Man Kyu Shim, Woo Jun Kim, Jiwoong Choi, Gi Hoon Nam, Jeongrae Kim, Jinseong Kim, Yujeong Moon, Han Young Kim, Jooho Park, Yoon Park, In San Kim, Ju Hee Ryu, Kwangmeyung Kim
Research output: Contribution to journal › Article › peer-review
65
Scopus
citations